Cited by 88Medication Adherence and ComplianceCystic Fibrosis Research AdvancesAdolescent and Pediatric Healthcare

Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis

Open access
Dziuban, Eric J., Saab‐Abazeed, Lisa, Chaudhry, Sarah R., Streetman, Daniel S., Nasr, Samya Z.·2010·Pediatric Pulmonology

Abstract

Introduction: The treatment of cystic fibrosis (CF) is directed toward correction of organ dysfunction and relief of symptoms resulting from the disease. Lack of adherence to daily treatment regimens may have substantial short‐term and long‐term effects on patients with CF. In this study, we attempted to identify barriers to treatment adherence which could be predicted by objective measures and explore ways to improve adherence in adolescents with CF. Methods: A questionnaire was given to patients 12.0–20.9 years of age, designed with focus on specific barriers to adhering to treatment plan and related attitudinal patterns. Observational and analytical results were collected. Results: We obtained questionnaires and objective health data for 60 respondents. The most commonly identified barriers to adherence were forgetting or losing medications (32/60) and being too busy (23/60). Attitudinal patterns that played a significant role for nonadherence included unintentional forgetting (40/60), feeling that following CF treatments resulted in less freedom in their lives (30/60), and believing it is acceptable to miss a treatment every few days (18/60) or to miss treatments when busy (18/60). Discussion: There were a few statistically significant differences of adherence patterns between demographic subgroups in our study. Males were more likely to agree that it is acceptable to miss doses if they are made up with extra doses later (24% vs. 3%, P = 0.04). Patients who perceived themselves to be less healthy agreed more to statements of limited freedom, nonsympathetic medical providers, and difficulty adhering during times of decreased symptoms. This highlights an unexpected risk: as CF progresses and patients perceive themselves to be less healthy, they may become less likely to be adherent during the periods they are feeling the best, while at the same time becoming less likely to perceive empathy from their physicians. Conclusions: Survey results describe a variety of beliefs and attitudinal patterns which contribute to nonadherence in CF treatment, especially relating to time management. While patients largely understood the importance of treatments to their health, predictors of risky behaviors could lead to targeted interventions by CF centers to address these challenges and improve adherence. Pediatr Pulmonol. 2010; 45:450–458. © 2010 Wiley‐Liss, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ppul.21195

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment beliefs (lack of perceived benefit, embarrassment, believing it is acceptable to miss treatments) have been reported to influence adherence in people with CF.

    “Treatment beliefs (e.g.lack of perceived benefit, feeling embarrassed about taking treatments in public, believing it is acceptable to miss treatments) have also been reported to influence adherence to treatments in people with CF (Bregnballe 2011;Bucks 2009;Dziuban 2010;George 2010;Sawicki 2015).”

    From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Dziuban 2010

    The Abstract reports that some adolescents believed it was acceptable to miss treatments, and the Discussion identifies embarrassment as a concern for younger adolescents. The paper does not specifically place that embarrassment in public; its Discussion suggests, rather than establishes, that perceived lack of benefit may contribute to missing airway-clearance therapy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Previous studies have commonly reported reasons for non-adherence including being too busy, forgetting, and treatment burden.

    “Previous studies have attempted to understand the factors influencing adherence to treatments in people with CF, and commonly reported reasons include being too busy or not having the time to take treatments, forgetting to take a treatment, and the level of treatment burden (Bregnballe 2011;Dziuban 2010;George 2010;Modi 2006a;Sawicki 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [22]22. de Jong W, Kaptein AA, van der Schans CP, Mannes GP, van Aalderen WM, Grevink RG, Koe ¨ter GH. Quality of life in patients with cystic fibrosis. Pediatr Pulmonol 1997;23:95- 100.
  2. [24]24. Riekert KA, Ridge A, Bilderback A, Hazle L, Marshall BC. Best practices in promoting patient/family treatment adherence: how are we doing? Pediatr Pulmonol Suppl 2008;31:40.

Cited by

Sorted by citations

Authors
Dziuban, E. J., Saab‐Abazeed, L., Chaudhry, S. R., Streetman, D. S., & Nasr, S. Z.
Affiliations
University of Michigan (US)
Corresponding author
Nasr, Samya Z.
Venue
Pediatric Pulmonology
Publisher
Wiley
Published
2010-04-05
Volume
45
Issue
5
Pages
450-458
ISSN
  • 1099-0496 (ISSN-L)
  • 8755-6863
OpenAlex
W2020684336
Cited by
88
References
23
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 10 · 2019: 8 · 2018: 5 · 2017: 12 · 2016: 4 · 2015: 8 · 2014: 8 · 2013: 2 · 2012: 8
FWCI
4.96
Type
journal article
Language
en
Open access
Locations
  • Pediatric Pulmonology (publishedVersion)
  • PubMed (publishedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Health Professions › Speech and Hearing › Adolescent and Pediatric Healthcare
Keywords
cystic fibrosis, medication adherence, medication non-adherence, adolescents, barriers to adherence, patient attitudes, forgetting medication, time management, health perception, sex differences
MeSH terms
Adolescent, Attitude to Health, Child, Cystic Fibrosis, Female, Humans, Male, Patient Compliance, Surveys and Questionnaires, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review